Contents

Current Topics in Medicinal Chemistry, Volume 16 - Number 12

Why Do We Need New Drug Classes for HIV Treatment and Prevention?

, 16(12): 1343 - 1349

Abdul A. Waheed and Gilda Tachedjian


DOI: 10.2174/1568026616999151013124606




Editorial

Editorial (Thematic Issue: Medicinal Chemistry of Hepatitis C Virus: Current and Future Perspective)

, 16(12): 1350

HaiWei Xu


DOI: 10.2174/156802661612160303150629




Computational Modelling in Studies for Hepatitis C Virus (HCV) NS3 Protease

, 16(12): 1351 - 1361

Azat Mukhametov


DOI: 10.2174/1568026616666151120112141





Current Drug Discovery for Anti-hepatitis C Virus Targeting NS4B

, 16(12): 1362 - 1371

Zhenya Wang, Xinli Chen, Chunli Wu, Haiwei Xu and Hongmin Liu


DOI: 10.2174/1568026616666151120112642





A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors

, 16(12): 1372 - 1382

Yan A. Ivanenkov, Mark S. Veselov, Artem G. Shakhbazyan, Vladimir A. Aladinskiy, Anastasia V. Aladinskaya, Sofya M. Yartseva, Alexander G. Majouga, Anton S. Vantskul, Sergey V. Leonov, Alexandre V. Ivachtchenko and Victor E. Koteliansky


DOI: 10.2174/1568026616666151120113040





In Silico Approaches to the Design of NS5A Inhibitors

, 16(12): 1383 - 1391

Yan A. Ivanenkov, Mark S. Veselov, Vladimir A. Aladinskiy, Artem G. Shakhbazyan, Sofya M. Yartseva, Alexander G. Majouga, Anastasia V. Aladinskaya, Anton S. Vantskul, Sergey V. Leonov, Alexandre V. Ivachtchenko and Victor E. Koteliansky


DOI: 10.2174/1568026616666151120113705





New Non-Nucleocide NS5B Protein Inhibitors for the Treatment of Chronic Hepatitis C Infection

, 16(12): 1392 - 1401

Li-hong Shan, Ying Liu, Yong-hong Li, Hong-min Liu and Yu Ke


DOI: 10.2174/1568026616666151120113933





HCV Inhibitors: Role of Compounds from Botanical Sources

, 16(12): 1402 - 1409

Vaishali M. Patil, Neeraj Masand and Satya Prakash Gupta


DOI: 10.2174/1568026616666151120112802





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science